An analysis of how cancer…
An analysis of how cancer drugmakers interact with oncologists found, [...]
An analysis of how cancer drugmakers interact with oncologists found, [...]
Generic versions of CSL’s iron replacement therapy Venofer have arrived [...]
The National Advertising Division has sided with Genomic Health in [...]
Vor Bio’s big bet on RemeGen’s autoimmune asset telitacicept appears [...]
Texas Attorney General Ken Paxton and Health Choice Alliance are [...]
As pharmas play up their U.S. investment plans during the [...]
With the new “Operation Access Now” program, BlinkRx claims drugmakers [...]
Under Robert F. Kennedy Jr., federal officials may withdraw an [...]
The former Texas governor and Trump energy secretary has now [...]
Cold Chain Technologies is eliminating 82 positions at its headquarters [...]